Clinical Trials Browser

Phase 4 × Breast Neoplasms × Genitourinary × Clear all

NCT07252726 2026-02-09

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Phase 4 Recruiting

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT04373564 2026-01-22

ODYSSEY

Phase 4 Recruiting

BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT05949424 2023-11-29

OPTI-DOSE

Phase 4 Unknown

BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT04074460 2022-06-09

VAPOR-C

Phase 4 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT00434317 2017-02-23

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Phase 4 Completed

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

NCT00334139 2017-02-07

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Phase 4 Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT00029224 2012-02-01

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Phase 4 Completed

BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms